My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$MDCO {{ '2016-02-01T14:47:26+0000' | timeago}} • Announcement

Specialty biopharmaceutical company $MNK said it closed the acquisition of the global portfolio of three commercial-stage topical hemostasis drugs from $MDCO. The portfolio includes Recothrom Thrombin topical (Recombinant), PreveLeak Surgical Sealant, and Raplixa (Fibrin Sealant (Human)).

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

User RC xNair {{ '2017-01-23T13:41:30+0000' | timeago}}

Excellent results from $MCD

User Melwyn Jones {{ '2017-01-20T20:15:31+0000' | timeago}}

$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.

User Doug Kubik {{ '2017-01-20T19:42:22+0000' | timeago}}

$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.

$ZION {{ '2017-01-23T22:53:22+0000' | timeago}} • Webcast

$ZION is committing to improve its efficiency ratio to the low 60s in 2017. The company saw soft loan growth in 4Q16, due to the constraints on growth in $ZION's commercial real estate portfolio as a result of internal concentration limits and attrition in oil and gas loans.

$TRST {{ '2017-01-23T22:45:08+0000' | timeago}} • Announcement

$TRST saw solid loan growth in 4Q16 compared to 4Q15, helped by an increase in residential mortgages. Loan portfolio expansion was funded primarily by growth of deposit base. The continued shift toward loans helped offset the margin impact from continued comparatively low yields on cash and investments.

$TRST {{ '2017-01-23T22:44:51+0000' | timeago}} • Announcement

Commercial bank $TRST reported 6.1% rise in its 4Q16 earnings. The company reported net income of $10.8M, or $0.113 per share compared to $10.2MM, or $0.107 during 4Q15. Net interest income rose to $36.9MM during the quarter compared to $36.2MM during 4Q15. Non-interest income rose to $4.51MM from $4.42 during 4Q15.

$RMD {{ '2017-01-23T22:44:41+0000' | timeago}} • Webcast

Given the cash flow level in 2Q17, $RMD said it is likely to commence its share repurchase program in FY18.

$RMD {{ '2017-01-23T22:27:00+0000' | timeago}} • Webcast

$RMD said that device sales in Americas grew 13% YoverY to $154.3MM in 2Q17. Device sales from the combined EMEA and Asia-Pacific grew 19% YoverY to $146.7MM.